Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-10-15 Purchase |
2024-10-17 4:19 pm |
Upstream Bio Inc. | UPB | Chimovits Erez Director 10% Owner |
825,000 | $17 | $14,025,000 | 4,554,873 (Indirect) |
View |
| 2024-10-15 Purchase |
2024-10-17 4:17 pm |
Upstream Bio Inc. | UPB | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Advisors Israel II Ltd OrbiMed Israel GP II L.P. Director 10% Owner |
825,000 | $17 | $14,025,000 | 4,554,873 (Indirect) |
View |
| 2024-10-15 Purchase |
2024-10-17 4:05 pm |
Upstream Bio Inc. | UPB | AI Upstream LLC AI Biotechnology LLC Access Industries Holdings LLC ACCESS INDUSTRIES MANAGEMENT LLC Blavatnik Len 10% Owner |
1,175,000 | $17 | $19,975,000 | 5,494,410 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-06 Option Award |
2025-02-07 5:32 pm |
N/A 2035-02-05 |
Upstream Bio Inc. | UPB | Sutherland Everett Rand Chief Executive Officer |
500,000 | $0 | 500,000 (Direct) |
View |
| 2025-02-06 Option Award |
2025-02-07 5:31 pm |
N/A 2035-02-05 |
Upstream Bio Inc. | UPB | GRAY MICHAEL CFO and COO |
195,000 | $0 | 195,000 (Direct) |
View |
| 2025-02-06 Option Award |
2025-02-07 5:29 pm |
N/A 2035-02-05 |
Upstream Bio Inc. | UPB | Houghton Adam Chief Business Officer |
140,000 | $0 | 140,000 (Direct) |
View |
| 2025-02-06 Option Award |
2025-02-07 5:29 pm |
N/A 2035-02-05 |
Upstream Bio Inc. | UPB | Deykin Aaron Chief Medical Officer |
165,000 | $0 | 165,000 (Direct) |
View |
| 2025-02-06 Option Award |
2025-02-07 5:25 pm |
N/A 2035-02-05 |
Upstream Bio Inc. | UPB | Ambrose Allison General Counsel |
25,000 | $0 | 25,000 (Direct) |
View |
| 2024-12-16 Option Award |
2024-12-17 4:18 pm |
N/A 2034-12-15 |
Upstream Bio Inc. | UPB | Ambrose Allison General Counsel |
100,000 | $0 | 100,000 (Direct) |
View |
| 2024-10-15 Conversion |
2024-10-17 4:19 pm |
N/A N/A |
Upstream Bio Inc. | UPB | Chimovits Erez Director 10% Owner |
7,219,578 | $0 | 4,554,873 (Indirect) |
View |
| 2024-10-15 Conversion |
2024-10-17 4:17 pm |
N/A N/A |
Upstream Bio Inc. | UPB | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Advisors Israel II Ltd OrbiMed Israel GP II L.P. Director 10% Owner |
7,219,578 | $0 | 4,554,873 (Indirect) |
View |
| 2024-10-15 Conversion |
2024-10-17 4:05 pm |
N/A N/A |
Upstream Bio Inc. | UPB | AI Upstream LLC AI Biotechnology LLC Access Industries Holdings LLC ACCESS INDUSTRIES MANAGEMENT LLC Blavatnik Len 10% Owner |
4,319,410 | $0 | 5,494,410 (Direct) |
View |
| 2024-10-15 Conversion |
2024-10-15 7:21 pm |
N/A N/A |
Upstream Bio Inc. | UPB | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 10% Owner |
1,747,673 | $0 | 894,733 (Direct) |
View |
| 2024-10-10 Option Award |
2024-10-15 4:15 pm |
N/A 2034-10-09 |
Upstream Bio Inc. | UPB | Chimovits Erez Director |
17,096 | $0 | 17,096 (Direct) |
View |
| 2024-10-10 Option Award |
2024-10-15 4:15 pm |
N/A 2034-10-09 |
Upstream Bio Inc. | UPB | Ruddy Marcella K. Director |
17,096 | $0 | 17,096 (Direct) |
View |
| 2024-10-10 Option Award |
2024-10-15 4:15 pm |
N/A 2034-10-09 |
Upstream Bio Inc. | UPB | Renaud Ronald C JR Director |
17,096 | $0 | 17,096 (Direct) |
View |
| 2024-10-10 Option Award |
2024-10-15 4:15 pm |
N/A 2034-10-09 |
Upstream Bio Inc. | UPB | Fleming Harold Edward Director |
17,096 | $0 | 17,096 (Direct) |
View |
| 2024-10-10 Option Award |
2024-10-15 4:15 pm |
N/A 2034-10-09 |
Upstream Bio Inc. | UPB | Beckman Daniella Director |
34,681 | $0 | 34,681 (Direct) |
View |
| 2024-10-10 Option Award |
2024-10-15 4:15 pm |
N/A 2034-10-09 |
Upstream Bio Inc. | UPB | Ratcliffe Liam Director |
17,096 | $0 | 17,096 (Direct) |
View |
Ownership |
2024-10-10 8:48 pm |
N/A N/A |
Upstream Bio Inc. | UPB | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 10% Owner |
0 | $0 | 894,733 (Direct) |
View |
Ownership |
2024-10-10 8:42 pm |
N/A 2034-04-03 |
Upstream Bio Inc. | UPB | Sutherland Everett Rand Chief Executive Officer |
0 | $0 | 1,920,503 (Direct) |
View |
Ownership |
2024-10-10 8:33 pm |
N/A N/A |
Upstream Bio Inc. | UPB | Chimovits Erez Director 10% Owner |
0 | $0 | 4,868,589 (Indirect) |
View |
Ownership |
2024-10-10 8:19 pm |
N/A 2032-01-01 |
Upstream Bio Inc. | UPB | Houghton Adam Chief Business Officer |
0 | $0 | 426,515 (Direct) |
View |
Ownership |
2024-10-10 8:14 pm |
N/A 2032-07-02 |
Upstream Bio Inc. | UPB | Ruddy Marcella K. Director |
0 | $0 | 64,141 (Direct) |
View |
Ownership |
2024-10-10 8:12 pm |
N/A 2032-06-03 |
Upstream Bio Inc. | UPB | Deykin Aaron Chief Medical Officer |
0 | $0 | 597,402 (Direct) |
View |
Ownership |
2024-10-10 8:09 pm |
N/A N/A |
Upstream Bio Inc. | UPB | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Advisors Israel II Ltd OrbiMed Israel GP II L.P. Director 10% Owner |
0 | $0 | 4,868,589 (Indirect) |
View |
Ownership |
2024-10-10 8:09 pm |
N/A 2032-01-01 |
Upstream Bio Inc. | UPB | Renaud Ronald C JR Director |
0 | $0 | 426,401 (Direct) |
View |
Ownership |
2024-10-10 8:09 pm |
N/A 2034-03-26 |
Upstream Bio Inc. | UPB | GRAY MICHAEL CFO and COO |
0 | $0 | 597,490 (Direct) |
View |
Ownership |
2024-10-10 4:27 pm |
N/A N/A |
Upstream Bio Inc. | UPB | AI Upstream LLC AI Biotechnology LLC Access Industries Holdings LLC ACCESS INDUSTRIES MANAGEMENT LLC Blavatnik Len 10% Owner |
0 | $0 | 4,117,646 (Direct) |
View |